EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Dual Role of NMDAR Containing NR2A and NR2B Subunits in Alzheimer’s Disease

Iu Raïch iD, Jaume Lillo, Joan Biel Rebassa iD, Toni Capó, Arnau Cordomí iD, Irene Reyes-Resina iD, Mercè Pallàs iD, Gemma Navarro iD

International Journal of Molecular Sciences · 26.04.2024 · 25 (9) · 4757

DOI: 10.3390/ijms25094757 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 26.04.2024. Verfasst von Iu Raïch und 7 weiteren Autor:innen. Beteiligte Einrichtung: Centro de Investigación Biomédica en Red de Enfermedades Neurodegenerativas (CiberNed), National Institute of Health Carlos III, 28029 Madrid, Spain. Hauptthemen laut MEDLINE: Receptors, N-Methyl-D-Aspartate, Alzheimer Disease, Neurons. Die Arbeit wurde bisher 22-mal zitiert (Crossref) und nennt 73 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Spanish Ministry of Economy and Innovation, Regional Catalonian Government.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Alzheimer’s disease (AD) is the main cause of dementia worldwide. Given that learning and memory are impaired in this pathology, NMDA receptors (NMDARs) appear as key players in the onset and progression of the disease. NMDARs are glutamate receptors, mainly located at the post-synapse, which regulate voltage-dependent influx of calcium into the neurons. They are heterotetramers, and there are different subunits that can be part of the receptors, which are usually composed of two obligatory GluN1 subunits plus either two NR2A or two NR2B subunits. NR2A are mostly located at the synapse, and their activation is involved in the expression of pro-survival genes. Conversely, NR2B are mainly extrasynaptic, and their activation has been related to cell death and neurodegeneration. Thus, activation of NR2A and/or inactivation of NR2B-containing NMDARS has been proposed as a therapeutic strategy to treat AD. Here, we wanted to investigate the main differences between both subunits signalling in neuronal primary cultures of the cortex and hippocampus. It has been observed that Aβ induces a significant increase in calcium release and also in MAPK phosphorylation signalling in NR2B-containing NMDAR in cortical and hippocampal neurons. However, while NR2A-containing NMDAR decreases neuronal death and favours cell viability after Aβ treatment, NR2B-containing NMDAR shows higher levels of cytotoxicity and low levels of neuronal survival. Finally, it has been detected that NMDAR has no effect on pTau axonal transport. The present results demonstrate a different role between GluNA and GluNB subunits in neurodegenerative diseases such as Alzheimer’s.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Receptors, N-Methyl-D-AspartateAlzheimer DiseaseNeuronsAnimalsHippocampusAmyloid beta-PeptidesCalciumHumansMicePhosphorylationCells, CulturedCerebral CortexRats

Stichwörter der Autor:innen

Alzheimer’s diseaseAβ oligomersNMDANMDARNR2ANR2BpTau

Substanzen

Receptors, N-Methyl-D-AspartateAmyloid beta-PeptidesCalciumNR2B NMDA receptorNR2A NMDA receptor

Autor:innen und Institutionen

  • Centro de Investigación Biomédica en Red de Enfermedades Neurodegenerativas (CiberNed), National Institute of Health Carlos III, 28029 Madrid, Spain.
  • Institut de Neurociències UB, Campus Mundet, Passeig de la Vall d'Hebron 171, 08035 Barcelona, Spain.
  • Department of Biochemistry and Physiology, Faculty of Pharmacy and Food Science, University of Barcelona, 08028 Barcelona, Spain.
  • Department of Biochemistry and Molecular Biomedicine, Faculty of Biology, University of Barcelona, 08028 Barcelona, Spain.
  • Bioinformatics, Escola Superior de Comerç Internacional-University Pompeu Fabra (ESCI-UPF), 08003 Barcelona, Spain.
  • Pharmacology Section, Department of Pharmacology, Toxicology, and Therapeutic Chemistry, Faculty of Pharmacy and Food Sciences, Av Joan XXIII 27-31, 08028 Barcelona, Spain.

ORCID-Profile: Iu Raïch, Joan Biel Rebassa, Arnau Cordomí, Irene Reyes-Resina, Mercè Pallàs, Gemma Navarro

Förderung

  • Spanish Ministry of Economy and Innovation
  • Regional Catalonian Government

Zitieren

APA

Raïch, I., Lillo, J., Rebassa, J. B., Capó, T., Cordomí, A., Reyes-Resina, I., Pallàs, M., & Navarro, G. (2024). Dual Role of NMDAR Containing NR2A and NR2B Subunits in Alzheimer’s Disease. International Journal of Molecular Sciences, 25(9), 4757. https://doi.org/10.3390/ijms25094757

Vancouver

Raïch I, Lillo J, Rebassa JB, Capó T, Cordomí A, Reyes-Resina I, et al. Dual Role of NMDAR Containing NR2A and NR2B Subunits in Alzheimer’s Disease. International Journal of Molecular Sciences. 2024;25(9):4757. doi:10.3390/ijms25094757

BibTeX
@article{Rach2024,
  author = {Raïch, Iu and Lillo, Jaume and Rebassa, Joan Biel and Capó, Toni and Cordomí, Arnau and Reyes-Resina, Irene and Pallàs, Mercè and Navarro, Gemma},
  title = {Dual Role of NMDAR Containing NR2A and NR2B Subunits in Alzheimer’s Disease},
  journal = {International Journal of Molecular Sciences},
  year = {2024},
  volume = {25},
  number = {9},
  pages = {4757},
  doi = {10.3390/ijms25094757}
}
Kostenlos starten →